dalteparin has been researched along with Hyphema in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Hyphema: Bleeding in the anterior chamber of the eye.
Excerpt | Relevance | Reference |
---|---|---|
" Intraoperative bleeding, postoperative fibrin, hyphema and vitreous hemorrhage were graded in an unmasked fashion using previously described grading scales." | 3.73 | A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy. ( Jumper, JM; Lane, RG; MacCumber, MW; McCuen, BW; Nasir, MA, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sharan, S | 1 |
Painter, G | 1 |
Grigg, JR | 1 |
Lane, RG | 1 |
Jumper, JM | 1 |
Nasir, MA | 1 |
MacCumber, MW | 1 |
McCuen, BW | 1 |
2 other studies available for dalteparin and Hyphema
Article | Year |
---|---|
Total hyphema following postoperative enoxaparin (Clexane).
Topics: Aged; Anticoagulants; Enoxaparin; Humans; Hyphema; Male; Postoperative Hemorrhage; Trabeculectomy | 2005 |
A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.
Topics: Diabetic Retinopathy; Enoxaparin; Female; Fibrin; Fibrinolytic Agents; Humans; Hyphema; Infusion Pum | 2005 |